CD40 and pancreatic adenocarcinoma: We used RNA sequencing data from The Cancer Genome Atlas (TCGA) database to analyze the correlation of CD40 expression and that of other protein-coding genes (n = 20,501) in samples from 534 clear cell renal cell carcinomas (ccRCC), 456 cutaneous melanomas, and 178 pancreatic adenocarcinomas, selecting tumor types that tend to be responsive to immunotherapy (melanoma and ccRCC) versus pancreatic adenocarcinoma which is resistant.